Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Martin

Showing results (101-110 of 101) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 101 results.
Clinical Immunology (Orlando, Fla.)|February 4, 2019
HLA- and genotype-based risk assessment model to identify infantile onset pompe disease patients at high-risk of developing significant anti-drug antibodies (ADA)A S De Groot, Z B Kazi, R F Martin, et al.
Pageof 11

Showing results (101-110 of 101) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 101 results.
Clinical Immunology (Orlando, Fla.)|February 4, 2019
HLA- and genotype-based risk assessment model to identify infantile onset pompe disease patients at high-risk of developing significant anti-drug antibodies (ADA)A S De Groot, Z B Kazi, R F Martin, et al.
Pageof 11